These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 24433082

  • 21. BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.
    Harper RL, Reynolds AM, Bonder CS, Reynolds PN.
    Respirology; 2016 May; 21(4):727-33. PubMed ID: 26809239
    [Abstract] [Full Text] [Related]

  • 22. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
    Vengethasamy L, Hautefort A, Tielemans B, Belge C, Perros F, Verleden S, Fadel E, Van Raemdonck D, Delcroix M, Quarck R.
    Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
    [Abstract] [Full Text] [Related]

  • 23. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics.
    Hiepen C, Jatzlau J, Hildebrandt S, Kampfrath B, Goktas M, Murgai A, Cuellar Camacho JL, Haag R, Ruppert C, Sengle G, Cavalcanti-Adam EA, Blank KG, Knaus P.
    PLoS Biol; 2019 Dec; 17(12):e3000557. PubMed ID: 31826007
    [Abstract] [Full Text] [Related]

  • 24. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M, Gomez-Puerto MC, Ten Dijke P.
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [Abstract] [Full Text] [Related]

  • 25. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
    Wang Y, Zhang XH, Wang HL.
    Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
    [Abstract] [Full Text] [Related]

  • 26. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A, Hecker M, Marsh LM, Kwapiszewska G, Nejman B, Long L, Seeger W, Schermuly RT, Morrell NW, Morty RE, Eickelberg O.
    Circulation; 2007 Jun 12; 115(23):2957-68. PubMed ID: 17515463
    [Abstract] [Full Text] [Related]

  • 27. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.
    Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, El-Bizri N, Sawada H, Haghighat R, Chan R, Haghighat L, de Jesus Perez V, Wang L, Reddy S, Zhao M, Bernstein D, Solow-Cordero DE, Beachy PA, Wandless TJ, Ten Dijke P, Rabinovitch M.
    J Clin Invest; 2013 Aug 12; 123(8):3600-13. PubMed ID: 23867624
    [Abstract] [Full Text] [Related]

  • 28. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension.
    Machado RD, James V, Southwood M, Harrison RE, Atkinson C, Stewart S, Morrell NW, Trembath RC, Aldred MA.
    Circulation; 2005 Feb 08; 111(5):607-13. PubMed ID: 15699281
    [Abstract] [Full Text] [Related]

  • 29. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J, Davies RJ, Southwood M, Long L, Yang X, Sobolewski A, Upton PD, Trembath RC, Morrell NW.
    Circ Res; 2008 May 23; 102(10):1212-21. PubMed ID: 18436795
    [Abstract] [Full Text] [Related]

  • 30. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    Long L, MacLean MR, Jeffery TK, Morecroft I, Yang X, Rudarakanchana N, Southwood M, James V, Trembath RC, Morrell NW.
    Circ Res; 2006 Mar 31; 98(6):818-27. PubMed ID: 16497988
    [Abstract] [Full Text] [Related]

  • 31. Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.
    Miyagawa K, Shi M, Chen PI, Hennigs JK, Zhao Z, Wang M, Li CG, Saito T, Taylor S, Sa S, Cao A, Wang L, Snyder MP, Rabinovitch M.
    Circ Res; 2019 Jan 18; 124(2):211-224. PubMed ID: 30582451
    [Abstract] [Full Text] [Related]

  • 32. PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension.
    Ali MK, Tian X, Zhao L, Schimmel K, Rhodes CJ, Wilkins MR, Nicolls MR, Spiekerkoetter EF.
    Cells; 2023 Jan 14; 12(2):. PubMed ID: 36672250
    [Abstract] [Full Text] [Related]

  • 33. Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension.
    Isobe S, Nair RV, Kang HY, Wang L, Moonen JR, Shinohara T, Cao A, Taylor S, Otsuki S, Marciano DP, Harper RL, Adil MS, Zhang C, Lago-Docampo M, Körbelin J, Engreitz JM, Snyder MP, Rabinovitch M.
    Nat Commun; 2023 Nov 21; 14(1):7578. PubMed ID: 37989727
    [Abstract] [Full Text] [Related]

  • 34. Endothelial-to-mesenchymal transition in pulmonary hypertension.
    Ranchoux B, Antigny F, Rucker-Martin C, Hautefort A, Péchoux C, Bogaard HJ, Dorfmüller P, Remy S, Lecerf F, Planté S, Chat S, Fadel E, Houssaini A, Anegon I, Adnot S, Simonneau G, Humbert M, Cohen-Kaminsky S, Perros F.
    Circulation; 2015 Mar 17; 131(11):1006-18. PubMed ID: 25593290
    [Abstract] [Full Text] [Related]

  • 35. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension.
    Aldred MA, Vijayakrishnan J, James V, Soubrier F, Gomez-Sanchez MA, Martensson G, Galie N, Manes A, Corris P, Simonneau G, Humbert M, Morrell NW, Trembath RC.
    Hum Mutat; 2006 Feb 17; 27(2):212-3. PubMed ID: 16429403
    [Abstract] [Full Text] [Related]

  • 36. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
    John A, Kizhakkedath P, Al-Gazali L, Ali BR.
    Gene; 2015 Apr 25; 561(1):148-56. PubMed ID: 25688877
    [Abstract] [Full Text] [Related]

  • 37. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R, Otsuka F, Nakamura K, Yamashita M, Otani H, Takeda M, Matsumoto Y, Kusano KF, Ito H, Makino H.
    Hypertens Res; 2010 May 25; 33(5):435-45. PubMed ID: 20186146
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X, Long L, Southwood M, Rudarakanchana N, Upton PD, Jeffery TK, Atkinson C, Chen H, Trembath RC, Morrell NW.
    Circ Res; 2005 May 27; 96(10):1053-63. PubMed ID: 15845886
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.
    Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, Ulrich S, Speich R, Huber LC.
    Circ Res; 2009 May 22; 104(10):1184-91. PubMed ID: 19390056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.